Category: Benchling

  • Benchling Acquires Overwatch Research to Accelerate Breakthroughs for Biopharma Companies

    What You Should Know: – Today, R&D Cloud pioneer Benchling announced it has acquired Overwatch Research to accelerate in vivo research. – The acquisition will create the industry’s first comprehensive, cloud-native in vivo solution – a critical component of drug discovery and development – drastically accelerating the time it takes biopharma companies to bring products […]

  • Connecting the Dots – Building Data Bridges for a Better Healthcare Future

    Jen Goldsmith, President Tendo Systems Healthcare data is increasing at an exponential rate. Approximately one-third of the world’s data volume is being generated by the healthcare industry. By 2025, the compound annual growth rate of healthcare data will reach 36% – that’s 6% faster than manufacturing, 10% faster than financial services, and 11% faster than […]

  • Biotech R&D Platform Benchling Closes $100M at $6B Valuation

    What You Should Know: Biotech R&D platform Benchling raises $100M at a $6B valuation, co-led by Franklin Templeton and Altimeter Capital to expand product development and global footprint, particularly in EMEA. More than 200,000 scientists at over 600 companies and 7,000 research institutions globally have adopted Benchling’s R&D Cloud to make breakthrough discoveries and bring […]

  • Led by Sequoia, Benchling Raises $200M to Accelerate R&D Cloud Platform

    – Today Benchling, the leading life and sciences R&D cloud, announced a $200M Series E raise led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital, and Elad Gil. This funding will be used to aggressively invest in product development and global expansion to support enterprise customers. The raise is also joined […]